These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2239133)

  • 1. High-dose praziquantel for neurocysticercosis: serum and CSF concentrations.
    Bittencourt PR; Gracia CM; Gorz AM; Oliveira TV
    Acta Neurol Scand; 1990 Jul; 82(1):28-33. PubMed ID: 2239133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.
    Jung H; Hurtado M; Sanchez M; Medina MT; Sotelo J
    Clin Neuropharmacol; 1990 Dec; 13(6):559-64. PubMed ID: 2276121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Praziquantel in the cerebrospinal fluid in neurocysticercosis.
    Spina-França A; Machado LR; Nóbrega JP; Livramento JA; Diekmann HW; Groll E; de Rezende GL
    Arq Neuropsiquiatr; 1985 Sep; 43(3):243-59. PubMed ID: 4091736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose praziquantel for neurocysticercosis: efficacy and tolerability.
    Bittencourt PR; Gracia CM; Gorz AM; Mazer S; Oliveira TV
    Eur Neurol; 1990; 30(4):229-34. PubMed ID: 2209679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of praziquantel levels in cerebrospinal fluid and plasma in patients with cysticercosis of the central nervous system treated with praziquantel].
    Jia JY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):174-6, 189-90. PubMed ID: 1889331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of neurocysticercosis with low-dose praziquantel.
    Pun KK; Wong WT
    Trop Geogr Med; 1984 Sep; 36(3):303-4. PubMed ID: 6506211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants.
    Dachman WD; Adubofour KO; Bikin DS; Johnson CH; Mullin PD; Winograd M
    J Infect Dis; 1994 Mar; 169(3):689-91. PubMed ID: 8158054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Praziquantel in the treatment of neurocysticercosis: long-term follow-up.
    Sotelo J; Torres B; Rubio-Donnadieu F; Escobedo F; Rodriguez-Carbajal J
    Neurology; 1985 May; 35(5):752-5. PubMed ID: 3990975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocysticercosis: regression of a fourth ventricular cyst with praziquantel.
    Allcut DA; Coulthard A
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):461-2. PubMed ID: 1865213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.
    Vazquez ML; Jung H; Sotelo J
    Neurology; 1987 Sep; 37(9):1561-2. PubMed ID: 3627459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ELISA (IgG and IgM) of the CSF and serum in neurocysticercosis under treatment with praziquantel: comparison with complement fixation reactions and immunofluorescence].
    Livramento JA; Costa JM; Machado LR; Nóbrega JP; Spina-França A
    Arq Neuropsiquiatr; 1985 Sep; 43(3):267-74. PubMed ID: 3911928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of praziquantel during the therapy of neurocysticerosis with praziquantel, in the presence of antiepileptics and dexamethasone.
    Na-Bangchang K; Vanijanonta S; Karbwang J
    Southeast Asian J Trop Med Public Health; 1995 Mar; 26(1):120-3. PubMed ID: 8525397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the therapeutic efficacy of praziquantel against human cysticercosis.
    Rim HJ; Joo KH
    Acta Leiden; 1989; 57(2):235-45. PubMed ID: 2489002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocysticercosis treated with praziquantel. Long-term follow-up of a case.
    Mancuso P; Chiaramonte I; Tropea R
    J Neurosurg Sci; 1991; 35(3):157-60. PubMed ID: 1774596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply from authors. Praziquantel in neurocysticercosis.
    Misra SC; Mansharamani GG
    J Assoc Physicians India; 1989 May; 37(5):352-3. PubMed ID: 2613654
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of praziquantel on intraocular cysticercosis: a case report.
    Kestelyn P; Taelman H
    Br J Ophthalmol; 1985 Oct; 69(10):788-90. PubMed ID: 4052366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of neurocysticercosis.
    Joubert J; Jenni WK
    S Afr Med J; 1990 Jan; 77(1):27-30. PubMed ID: 2294609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysticercal meningitis--a pernicious form of neurocysticercosis which responds poorly to praziquantel.
    Joubert J
    S Afr Med J; 1990 May; 77(10):528-30. PubMed ID: 2343353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolonged treatment of recurrent neurocysticercosis using sequential doses of albendazole and praziquantel].
    Chagnon A; Galzin M; de Jaureguiberry JP; Boyer B; Paris JF; Marlier S; Carli P
    Med Trop (Mars); 1994; 54(3):275-6. PubMed ID: 7885211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.